Betahistine
Also known as: Betahistine hydrochloride
Brand names: SERC
Therapeutic Indications
Betahistine is indicated for:
Ménière's syndrome
Irrespective of gender only Adults (18 years old or older)
Vertigo, tinnitus and hearing loss associated with Ménière’s syndrome.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Oral - 24-48 mg in 3 divided doses daily
Contraindications
Active ingredient Betahistine is contraindicated in the following cases:
Pheochromocytoma
No gender/age discrimination